TXG: 10X Genomics, Inc.
About
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Current Value
$13.611 Year Return
Current Value
$13.611 Year Return
Key Details
Market Cap
$1.64B
P/E Ratio
-8.89
1Y Stock Return
-68.30%
1Y Revenue Growth
6.56%
Dividend Yield
0.00%
Price to Book
2.3
Strategies that include TXG
Stock's related to TXG
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PACB | 54.58% | $471.05M | -79.23% | 0.00% |
| CRL | 52.55% | $9.52B | -3.20% | 0.00% |
| U | 52.47% | $7.98B | -30.33% | 0.00% |
| ALG | 51.14% | $2.30B | +4.01% | 0.55% |
| IQV | 51.07% | $34.73B | -7.77% | 0.00% |
| OPEN | 50.86% | $1.14B | -31.62% | 0.00% |
| BXC | 50.85% | $1.01B | +40.40% | 0.00% |
| VSH | 50.38% | $2.07B | -31.61% | 2.64% |
| ICUI | 50.06% | $4.15B | +104.38% | 0.00% |
| LESL | 49.59% | $532.55M | -48.75% | 0.00% |
| PLL | 49.48% | $238.11M | -56.47% | 0.00% |
| RLJ | 49.40% | $1.47B | -7.25% | 4.71% |
| XHR | 49.23% | $1.51B | +19.71% | 3.13% |
| ANGO | 49.21% | $273.06M | -0.59% | 0.00% |
| STHO | 49.17% | $150.51M | -5.99% | 0.00% |
| SBCF | 49.13% | $2.50B | +28.16% | 2.45% |
| ASTH | 49.12% | $2.01B | +24.82% | 0.00% |
| BIGC | 49.07% | $473.42M | -31.75% | 0.00% |
| TFIN | 49.06% | $2.34B | +43.04% | 0.00% |
| FRME | 49.01% | $2.51B | +38.53% | 3.21% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LITB | <0.01% | $35.48M | -75.45% | 0.00% |
| JNPR | -0.03% | $11.61B | +30.55% | 2.49% |
| GAN | -0.05% | $83.39M | +21.19% | 0.00% |
| UTHR | 0.06% | $16.10B | +56.54% | 0.00% |
| BTCT | 0.07% | $42.61M | +353.33% | 0.00% |
| CAH | 0.07% | $28.64B | +12.14% | 1.70% |
| RSG | 0.07% | $66.05B | +31.79% | 1.04% |
| UVE | -0.15% | $631.63M | +36.40% | 2.86% |
| GO | 0.29% | $1.81B | -34.42% | 0.00% |
| SRDX | 0.37% | $559.12M | +15.64% | 0.00% |
| TXO | 0.54% | $737.26M | -1.80% | 13.22% |
| APRE | 0.62% | $16.41M | -19.47% | 0.00% |
| CCEC | 0.63% | $1.02B | +28.03% | 3.26% |
| CYD | -0.83% | $364.46M | -2.94% | 4.26% |
| NERV | -0.88% | $14.69M | -58.00% | 0.00% |
| LPLA | 0.91% | $23.55B | +38.13% | 0.38% |
| NNE | 0.94% | $833.66M | +531.50% | 0.00% |
| KSPI | -1.02% | $20.86B | +18.06% | 3.37% |
| HCI | -1.02% | $1.16B | +29.00% | 1.48% |
| TPST | 1.03% | $37.75M | -77.59% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -21.23% | $78.15B | +35.51% | 0.42% |
| PGR | -19.47% | $149.10B | +57.29% | 0.45% |
| CBOE | -16.65% | $21.46B | +15.84% | 1.11% |
| ACGL | -16.45% | $36.00B | +16.84% | 0.00% |
| ALL | -15.28% | $52.06B | +45.67% | 1.85% |
| RNR | -13.30% | $13.74B | +23.09% | 0.58% |
| FATBB | -12.96% | $81.94M | -12.91% | 11.69% |
| HUSA | -12.41% | $16.69M | -11.56% | 0.00% |
| AJG | -11.90% | $64.17B | +17.51% | 0.80% |
| MSDL | -11.56% | $1.83B | +0.66% | 7.26% |
| PULM | -11.05% | $19.83M | +202.98% | 0.00% |
| VIRT | -10.06% | $3.17B | +110.38% | 2.60% |
| MNR | -9.85% | $1.66B | -10.71% | 15.90% |
| EG | -9.33% | $15.92B | -8.98% | 2.02% |
| HIHO | -8.09% | $8.63M | 0.00% | 6.12% |
| CPB | -7.64% | $12.96B | +7.08% | 3.40% |
| CHD | -7.62% | $27.18B | +19.50% | 1.03% |
| GIS | -7.56% | $34.85B | -2.91% | 3.78% |
| OXBR | -7.37% | $19.05M | +178.18% | 0.00% |
| PG | -6.46% | $402.15B | +14.14% | 2.33% |
ETF's related to TXG
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | 62.87% | $1.13B | 0.75% |
| DFSV | 62.26% | $4.16B | 0.31% |
| RWJ | 57.86% | $1.75B | 0.39% |
| EES | 57.78% | $668.71M | 0.38% |
| SLYG | 57.54% | $3.69B | 0.15% |
| DFAT | 57.28% | $11.16B | 0.28% |
| RZV | 56.94% | $258.76M | 0.35% |
| IJJ | 56.80% | $8.03B | 0.18% |
| EZM | 56.79% | $823.84M | 0.38% |
| IBUY | 56.77% | $176.17M | 0.65% |
| MOAT | 56.76% | $15.73B | 0.46% |
| EDOC | 56.41% | $40.86M | 0.68% |
| XRT | 56.20% | $451.85M | 0.35% |
| KOMP | 55.93% | $2.09B | 0.2% |
| SMOT | 55.79% | $374.04M | 0.49% |
| GNOM | 55.68% | $70.59M | 0.5% |
| VBK | 55.34% | $19.31B | 0.07% |
| PBW | 55.25% | $301.18M | 0.65% |
| NUSC | 55.12% | $1.27B | 0.31% |
| VB | 55.10% | $63.63B | 0.05% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BILZ | -0.18% | $563.02M | 0.14% |
| DBA | 0.21% | $755.88M | 0.93% |
| ULST | 0.32% | $535.47M | 0.2% |
| XBIL | -0.37% | $637.70M | 0.15% |
| TBIL | -0.54% | $4.38B | 0.15% |
| HDRO | 0.86% | $164.26M | 0.3% |
| XHLF | -1.09% | $874.27M | 0.03% |
| WEAT | 1.20% | $120.27M | 0.28% |
| JUCY | 1.26% | $324.29M | 0.6% |
| KCCA | -1.28% | $220.51M | 0.87% |
| UNG | 1.76% | $908.80M | 1.06% |
| CORN | 1.93% | $61.12M | 0.2% |
| MINT | 1.97% | $11.62B | 0.35% |
| FMF | -2.06% | $244.61M | 0.95% |
| SGOV | 2.70% | $27.53B | 0.09% |
| JBBB | 2.85% | $1.26B | 0.49% |
| IBHD | 3.00% | $327.80M | 0.35% |
| CSHI | -3.04% | $482.85M | 0.38% |
| BSCO | -3.08% | $2.35B | 0.1% |
| DBE | -3.42% | $50.13M | 0.77% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -48.24% | $388.04M | 1.43% |
| USDU | -29.43% | $201.97M | 0.5% |
| UUP | -26.72% | $309.25M | 0.77% |
| VIXY | -25.98% | $195.31M | 0.85% |
| EQLS | -16.95% | $76.08M | 1% |
| TAIL | -16.91% | $67.98M | 0.59% |
| CTA | -14.49% | $350.27M | 0.78% |
| KMLM | -5.94% | $353.87M | 0.9% |
| HIGH | -5.69% | $302.78M | 0.51% |
| AGZD | -4.87% | $142.76M | 0.23% |
| CLOI | -4.43% | $715.40M | 0.4% |
| DBE | -3.42% | $50.13M | 0.77% |
| BSCO | -3.08% | $2.35B | 0.1% |
| CSHI | -3.04% | $482.85M | 0.38% |
| FMF | -2.06% | $244.61M | 0.95% |
| KCCA | -1.28% | $220.51M | 0.87% |
| XHLF | -1.09% | $874.27M | 0.03% |
| TBIL | -0.54% | $4.38B | 0.15% |
| XBIL | -0.37% | $637.70M | 0.15% |
| BILZ | -0.18% | $563.02M | 0.14% |
News
Finnhub
10x Genomics and Hamilton Company Partner to Enable Single Cell Workflow Automation PLEASANTON, Calif., Nov. 20, 2024 - 10x Genomics, Inc. , a leader in single cell and...
Yahoo
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in the genomics […]
Finnhub
10x Genomics and Beckman Coulter Life Sciences Launch New Solution to Automate Single Cell Assay Workflows PLEASANTON, Calif., Nov. 18, 2024 -- 10x Genomics, Inc. , a leader...
Yahoo
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Wolfe Research 2024 Healthcare Conference on Tuesday, November 19, at 1:00 p.m. Eastern Time.
Yahoo
Investors in 10x Genomics, Inc. ( NASDAQ:TXG ) had a good week, as its shares rose 3.5% to close at US$16.03 following...
Yahoo
French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Cure51 will deploy 10x Genomics' Visium HD as part of its pioneering work to understand the unique biology of exceptional cancer survivors, whose survival mechanisms could hold the key to new therapeutic approaches. Working alongside more than 50 medical institutions, Cure51 intends to collect and analyze tumor tissues from over 1,000 exceptional cancer survivors
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.